Synergistic activity of letrozole and sorafenib on breast cancer cells. [electronic resource]
- Breast cancer research and treatment Nov 2010
- 79-88 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-7217
10.1007/s10549-009-0714-5 doi
Adaptor Proteins, Signal Transducing--metabolism Antineoplastic Combined Chemotherapy Protocols--pharmacology Apoptosis--drug effects Apoptosis Inducing Factor--metabolism Aromatase--genetics Aromatase Inhibitors--pharmacology Benzenesulfonates--pharmacology Breast Neoplasms--enzymology Caspase 7--metabolism Caspase 9--metabolism Cell Cycle--drug effects Cell Cycle Proteins Cell Line, Tumor Cell Proliferation--drug effects Cyclin D1--metabolism Cytochromes c--metabolism Dose-Response Relationship, Drug Drug Resistance, Neoplasm Drug Synergism Estradiol--metabolism Female Humans Letrozole Mechanistic Target of Rapamycin Complex 1 Multiprotein Complexes Niacinamide--analogs & derivatives Nitriles--pharmacology Phenylurea Compounds Phosphoproteins--metabolism Phosphorylation Poly (ADP-Ribose) Polymerase-1 Poly(ADP-ribose) Polymerases--metabolism Protein Kinase Inhibitors--pharmacology Proteins--metabolism Proto-Oncogene Proteins c-myc--metabolism Pyridines--pharmacology Retinoblastoma Protein--metabolism Ribosomal Protein S6 Kinases, 70-kDa--metabolism Sorafenib TOR Serine-Threonine Kinases Testosterone--metabolism Time Factors Transfection Triazoles--pharmacology